Cargando…

The Costs and Health Benefits of Expanded Access to MDMA-assisted Therapy for Chronic and Severe PTSD in the USA: A Modeling Study

BACKGROUND AND OBJECTIVE: Intensive psychotherapy assisted with 3,4-methylenedioxymethamphetamine (MDMA-AT) was shown in Phase 3 clinical trials to substantially reduce post-traumatic stress disorder (PTSD) symptoms compared to psychotherapy with placebo. This study estimates potential costs, health...

Descripción completa

Detalles Bibliográficos
Autores principales:	Avanceña, Anton L. V., Kahn, James G., Marseille, Elliot
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930905/ https://www.ncbi.nlm.nih.gov/pubmed/35230652 http://dx.doi.org/10.1007/s40261-022-01122-0

Ejemplares similares

The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD
por: Marseille, Elliot, et al.
Publicado: (2020)

Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial
por: Marseille, Elliot, et al.
Publicado: (2022)

Correction: Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial
por: Marseille, Elliot, et al.
Publicado: (2022)

MDMA-assisted psychotherapy for the treatment of PTSD
por: Reiff, Collin M., et al.
Publicado: (2020)

Premise, promise and challenges of MDMA assisted therapy for PTSD
por: Madero, Santiago, et al.
Publicado: (2023)

A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy
por: Sottile, Robert J., et al.
Publicado: (2022)

Psychotherapy-supported MDMA treatment for PTSD
por: Krystal, John H., et al.
Publicado: (2021)

MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial
por: Mitchell, Jennifer M., et al.
Publicado: (2023)

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
por: Mitchell, Jennifer M., et al.
Publicado: (2021)

MDMA-assisted psychotherapy for people diagnosed with treatment-resistant PTSD: what it is and what it isn’t
por: Morgan, Louise
Publicado: (2020)

Efficacy and safety results from the first pivotal phase 3 randomized controlled trial of mdma-assisted psychotherapy for treatment of severe chronic PTSD
por: Van Der Kolk, B.
Publicado: (2021)

MDMA-assisted psychotherapy; Inclusion of transgender and gender diverse people in the frontiers of PTSD treatment trials
por: Stauffer, Christopher S., et al.
Publicado: (2022)

Relational and Growth Outcomes Following Couples Therapy With MDMA for PTSD
por: Wagner, Anne C., et al.
Publicado: (2021)

Perceived key change phenomena of MDMA-assisted psychotherapy for the treatment of severe PTSD: an interpretative phenomenological analysis of clinical integration sessions
por: Godes, Macha, et al.
Publicado: (2023)

Innovations in cost-effectiveness analysis that advance equity can expand its use in health policy
por: Avanceña, Anton L.V., et al.
Publicado: (2022)

A comparison of mdma-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis
por: Illingworth, B., et al.
Publicado: (2021)

Utilitarianism and the ethical foundations of cost-effectiveness analysis in resource allocation for global health
por: Marseille, Elliot, et al.
Publicado: (2019)

Bubble continuous positive airway pressure in the treatment of severe paediatric pneumonia in Malawi: a cost-effectiveness analysis
por: Kortz, Teresa Bleakly, et al.
Publicado: (2017)

The economics of psychedelic-assisted therapies: A research agenda
por: Marseille, Elliot, et al.
Publicado: (2022)

Self-reported PTSD is associated with increased use of MDMA in adolescents with substance use disorders
por: Basedow, Lukas Andreas, et al.
Publicado: (2021)

Pilot study suggests DNA methylation of the glucocorticoid receptor gene (NR3C1) is associated with MDMA-assisted therapy treatment response for severe PTSD
por: Lewis, Candace R., et al.
Publicado: (2023)

Cost-Effectiveness of Male Circumcision for HIV Prevention in a South African Setting
por: Kahn, James G, et al.
Publicado: (2006)

Coping motives mediate the relationship between PTSD and MDMA use in adolescents with substance use disorders
por: Basedow, Lukas Andreas, et al.
Publicado: (2022)

Cost-effectiveness analysis of a physician deployment program to improve access to healthcare in rural and underserved areas in the Philippines
por: Avanceña, Anton L.V., et al.
Publicado: (2019)

Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials
por: Jerome, Lisa, et al.
Publicado: (2020)

MDMA-Assisted Therapy for Treatment-Resistant Posttraumatic Stress Disorder (PTSD) – One step further toward a patient-centered treatment pathway
por: Pratas Penedos, S., et al.
Publicado: (2022)

Thresholds for the cost–effectiveness of interventions: alternative approaches
por: Marseille, Elliot, et al.
Publicado: (2015)

Psilocybin and MDMA reduce costly punishment in the Ultimatum Game
por: Gabay, Anthony S., et al.
Publicado: (2018)

Scaling up integrated prevention campaigns for global health: costs and cost-effectiveness in 70 countries
por: Marseille, Elliot, et al.
Publicado: (2014)

Cost-Effectiveness of Antiretroviral Therapy for Prevention
por: Kahn, James G, et al.
Publicado: (2011)

MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
por: Mithoefer, Michael C., et al.
Publicado: (2019)

Adult male circumcision in Nyanza, Kenya at scale: the cost and efficiency of alternative service delivery modes
por: Marseille, Elliot, et al.
Publicado: (2014)

Current Perspective on MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder
por: Thal, Sascha B., et al.
Publicado: (2018)

A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy
por: Sessa, Ben, et al.
Publicado: (2019)

MDMA treatment paired with a trauma-cue promotes adaptive stress responses in a translational model of PTSD in rats
por: Arluk, Shira, et al.
Publicado: (2022)

MDMA administration attenuates hippocampal IL-β immunoreactivity and subsequent stress-enhanced fear learning: An animal model of PTSD
por: Parekh, Shveta V., et al.
Publicado: (2022)

Expanded testing for COVID-19 could be cost effective in USA
Publicado: (2020)

Methaemoglobinemia Induced by MDMA?
por: Verhaert, L. L. W.
Publicado: (2011)

Correction to: Current Perspective on MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder
por: Thal, Sascha B., et al.
Publicado: (2018)

Posttraumatic Growth After MDMA‐Assisted Psychotherapy for Posttraumatic Stress Disorder
por: Gorman, Ingmar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1s288utk4385b75825uat7r35r